Keyphrases
Genetic Modification
100%
Cardiovascular Risk
100%
Coronary Risk Factors
100%
NO-cGMP Pathway
100%
Associated Proteins
50%
Genome-wide Association Study
50%
Genetic Findings
50%
Coronary Artery Disease
50%
Risk Factors
50%
Risk Genes
50%
Cardiovascular Disease
50%
Inositol 1,4,5-trisphosphate Receptor (IP3R)
50%
Blood Pressure
50%
Phosphodiesterase Type 5 Inhibitors
50%
Endothelial Nitric Oxide Synthase (eNOS)
50%
Therapeutic Implications
50%
Phosphodiesterase 3 (PDE3)
50%
Chromosomal Locus
50%
Soluble Guanylyl Cyclase
50%
GUCY1A3
50%
PDE3A
50%
NOS3
50%
MRVI1
50%
NO-cGMP Signaling
50%
PDE5A
50%
Biochemistry, Genetics and Molecular Biology
Genetics
100%
Gene Mutation
100%
Blood Pressure
100%
Inositol 1,4,5 Trisphosphate Receptor
100%
Genome-Wide Association Study
100%
Phosphodiesterase
100%
Guanylate Cyclase
100%
Nitric Oxide Synthase
100%
Pharmacology, Toxicology and Pharmaceutical Science
Coronary Artery Disease
100%
Cardiovascular Risk
100%
Atherosclerosis
33%
Phosphodiesterase
33%
Endothelial Nitric Oxide Synthase
33%
Guanylate Cyclase
33%
Inositol 1,4,5 Trisphosphate Receptor
33%
Cardiovascular Disease
33%